adenosine monophosphate has been researched along with Thromboembolism in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angiolillo, DJ; Banerjee, S; Bhatt, DL; Cantrell, S; Jones, WS; Mehran, R; Nanna, MG; Ohman, EM; Rao, SV; Rymer, JA; Sullivan, AE; Wang, TY; Washam, JB | 1 |
| Absi, M; Beasley, G; Boston, U; Sainathan, S | 1 |
| Di Perri, G | 1 |
| Heemskerk, JW; Heijnen, VV; oude Egbrink, MG; Reneman, RS; Slaaf, DW; van Gestel, MA | 1 |
| Jobin, F | 1 |
2 review(s) available for adenosine monophosphate and Thromboembolism
| Article | Year |
|---|---|
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
Topics: Adenosine Monophosphate; Eptifibatide; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thromboembolism; Tirofiban | 2021 |
Acetylsalicylic acid, hemostasis and human thromboembolism.
Topics: Adenosine Monophosphate; Aspirin; Blood Coagulation Tests; Blood Platelets; Cardiac Catheterization; Cerebrovascular Disorders; Complement System Proteins; Coronary Disease; Dose-Response Relationship, Drug; Fibrinolysis; Guanosine Monophosphate; Heart Valve Prosthesis; Hemostasis; Humans; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins; Thromboembolism | 1978 |
3 other study(ies) available for adenosine monophosphate and Thromboembolism
| Article | Year |
|---|---|
Use of a novel antiplatelet agent cangrelor in an infant supported with a ventricular assist device.
Topics: Adenosine Monophosphate; Fontan Procedure; Heart-Assist Devices; Humans; Hypoplastic Left Heart Syndrome; Infant; Male; Norwood Procedures; Palliative Care; Platelet Aggregation Inhibitors; Thromboembolism; Treatment Outcome; Ventricular Dysfunction | 2020 |
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Disease Management; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Embolism; Endothelium, Vascular; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Macrophage Activation; Pandemics; Pneumonia, Viral; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Ritonavir; Thromboembolism; Thrombophilia; Thrombosis | 2020 |
In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
Topics: Adenosine Monophosphate; Administration, Oral; Animals; Blood Platelets; Calcium; Clopidogrel; Female; Male; Membrane Proteins; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Rabbits; Receptors, Purinergic P2Y12; Thrombin; Thromboembolism; Ticlopidine | 2003 |